Phage delivered CRISPR-Cas system to combat multidrug-resistant pathogens in gut microbiome
2022 · Biomedicine & Pharmacotherapy · 78 citations
https://doi.org/10.1016/j.biopha.2022.113122
A
Adrija Sinha
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
64
Papers
1.2K
Citations
20
h-index
33
i10-index
Adrija Sinha is an academic researcher from Carestream (United States). The author has contributed to research in topics: Nanoparticles: synthesis and applications & Multiferroics and related materials & Graphene and Nanomaterials Applications. The author has an h-index of 20, co-authored 55 publications.
ORCID: 0000-0001-8105-6265Papers by this author
worksZebrafish (Danio rerio) as an ecotoxicological model for Nanomaterial induced toxicity profiling
2021 · Precision Nanomedicine · 48 citations
https://doi.org/10.33218/001c.21978
The posterity of Zebrafish in paradigm of in vivo molecular toxicological profiling
2024 · Biomedicine & Pharmacotherapy · 40 citations
https://doi.org/10.1016/j.biopha.2024.116160
In silico nanotoxicology: The computational biology state of art for nanomaterial safety assessments
2023 · Materials & Design · 32 citations
https://doi.org/10.1016/j.matdes.2023.112452
Perilous paradigm of graphene oxide and its derivatives in biomedical applications: Insight to immunocompatibility
2024 · Biomedicine & Pharmacotherapy · 25 citations
https://doi.org/10.1016/j.biopha.2024.116842
Biofilm modifiers: The disparity in paradigm of oral biofilm ecosystem
2023 · Biomedicine & Pharmacotherapy · 24 citations
https://doi.org/10.1016/j.biopha.2023.114966
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat